跳至主要内容
临床试验/NCT00041548
NCT00041548终止1 期

Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation

Mallinckrodt1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2002年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
发起方
Mallinckrodt
入组人数
7
试验地点
1
主要终点
PaO2 level

研究概览

简要总结

The purpose of this pilot study is to evaluate whether administration of nitric oxide (NO)gas by oxygen hood at 20 ppm significantly increases PaO2, as compared to placebo gas (oxygen), within one hour of initiation and with no significant adverse effects.

详细描述

It is possible that administration of inhaled NO to neonates with abnormal gas exchange earlier, rather than later as a rescue therapy in a moribund state, might accelerate the transition of the circulation from the fetal to neonatal physiology and improve oxygenation. This may in turn decrease the need for mechanical ventilation, its associated morbidity and perhaps even ECMO.

This study is designed as a pilot study to evaluate the physiologic efficacy (rather than effect on clinical outcomes) of NO administered by hood in improving oxygenation of neonates with elevated A-a DO2.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
— 至 120 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

1

Experimental

Nitric Oxide for Inhalation

干预措施: nitric oxide for inhalation (Drug)

2

Placebo Comparator

oxygen

干预措施: Oxygen (Drug)

结局指标

主要结局

PaO2 level

时间窗: at baseline, then every hour for 6 hours

次要结局

  • Alveolar-arterial oxygen gradient and ratio(after 1 hour of treatment)
  • Methemoglobin level(at baseline then every hour of treatment)

研究者

发起方
Mallinckrodt
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验